Abasaglar ® (basal insulin glargine)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Abasaglar Summary of Product Characteristics (SmPC)

Abasaglar® (insulin glargine): Missed dose

In the event of a missed dose of Abasaglar, physicians may use their clinical discretion based on the patient's situation.

Detailed Information

There is no one rule on what to do in the event of a missed dose of insulin, including IGlar.

Patients with a missed dose of Abasaglar should :

  • test their blood glucose and their urine for ketones as soon as any symptoms of hyperglycaemia occur,1

  • monitor their blood glucose frequently,1

  • do not take a double dose to make up for a forgotten dose, and 1

  • contact their physician.1

For patients who miss a dose of Abasaglar, physicians may use their clinical discretion regarding resumption of dosing. Factors that may be considered by physicians include :

  • the wide spectrum of disease progression

  • individual dosing ranges

  • time from the missed dose, and

  • concomitant medications.


1. Abasaglar [package leaflet: information for the patient]. Eli Lilly Nederland B.V., The Netherlands.


Abasaglar = Abasaglar® (insulin glargine) 100 units/mL

IGlar = insulin glargine

Date of Last Review: December 06, 2019

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request